RiboTech Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RiboTech Co., Ltd. - overview
Established
2020
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 2022, RiboTech Co. , Ltd. is a vaccine research and development company specializing in lariat and circular mRNA-based theraputics. In January 2025, RiboTech Co.
, Ltd. raised KRW 2. 5 billion in pre-series A funding from DAYLI Partners and Union Investment Partners. RiboTech Co.
, Ltd create mRNA-based therapies using lariat and circular structures to address the limitations of current commercial mRNA platforms. Unlike traditional vaccines that deliver antigens directly, mRNA vaccines provide genetic information, prompting cells to produce antigen proteins and trigger immune responses. Along with vaccines for preventing infectious diseases, there's growing interest in developing mRNA-based anticancer vaccines for cancer treatment. The company plans to use the January 2025 funding to expedite the development of a lariat mRNA-based anticancer vaccine.
Current Investors
Union Investment Partners, DAYLI Partners, Penture Invest
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
RiboTech Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|
| Revenue (USD) | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | - | - | - | - |
| Operating Income (USD) | (735,000) | - | - | - |
| Operating Margin | - | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | (725,000) | - | - | - |
| % Net Margin | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.